Part of


Can\'t find something? Send feedback
Mar
19
0
1:18 PM Sources: StreetInsider.com
Although the stock is still down about 0.8% for the sessions, shares of Sanofi Aventis (NYSE: SNY ) have now pushed to fresh intraday highs. The stock began moving sharply higher just after noon following an intraday upgrade from an analyst at Cantor Fitzgerald. The firm now rates Sanofi a Buy, up from a previous Selling rating.  

Mar
19
0
10:58 AM Sources: Pharma Marketing Blog
According to Chris Kenton of SmartMarketers.com's Inspire Blog , "Surprisingly few companies... have protocols in place to manage social media disasters as they unfold -- even those that have sophisticated crisis management protocols in place for non-social media issues." Many pharmaceutical companies may be guilty of that lapse in their crisis management strategy. This topic came up today in the #hcsmeu Twitter discussion around Sanofi-Aventis and its VOICES Facebook fiasco (for the story background, s  
more news on: Social networks news

Mar
19
0
9:28 AM Sources: PharmaLive
Jeffrey B. Kindler, Chairman and Chief Executive Officer, Pfizer, was elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association's annual meeting. Also elected were sanofi-aventis Chief Executive Officer Christopher Viehbacher as chairman-elect of the PhRMA Board of Directors, and John C. Lechleiter, Ph.D., Chairman, President and Chief Executive Officer of Eli Lilly and Company, as board treasurer. Mr. Kindler succeeds David R. Brennan, Chi

I am proud of the accomplishments of PhRMA over the past year. During a year of many changes and uncertainties, PhRMA and its member companies worked diligently to address the health care challenges facing the United States while remaining committed to our goal of promoting solutions for patients   -David R Brennan

 

Mar
18
0
2:34 PM Sources: eGov Monitor
International trademark filings under WIPO's Madrid System for the International Registration of Marks ("the Madrid system") dropped by 16% in 2009 as a result of the global economic downturn, though increases were observed among some major users of the system, notably the European Union (EU) (3.1%) and Japan (2.7%), as well as in the Republic of Korea (ROK) (+33.9%), Singapore (+20.5%), Croatia (+17.5%) and Hungary (+14.5%). WIPO received 35,195 international applications under the 84-member Madrid syste

Historically, we know that demand for intellectual property rights declines in periods of recession. These downturns are more strongly and rapidly felt in the area of trademarks which are more closely tied to market conditions. Demand for intellectual property rights, however, had reached unprecedented levels prior to the crisis and we have every reason to believe that international trademark activity will pick up as economic growth solidifies and broadens.   -Francis Gurry

 

Mar
18
0
9:02 AM Sources: PRNewswireUS
NEW YORK , March 18 /PRNewswire/ -- Euro RSCG Worldwide announced today that two of the company's top leaders will be teaching two online courses at New York University : Examining Social Media Networks for Brand Value and Beyond Twitter and Facebook: The Next Platform. Marian Salzman , president of Euro RSCG Worldwide PR, North America , in New York , and Christopher Hayes , marketing director of Euro RSCG 4D Amsterdam , will conduct the first four-session course beginning on March 20, 20

More and more brands are looking for ways to break through the enormous clutter created by the explosion of social networks and nontraditional marketing   -Christopher Hayes

 

Mar
18
0
7:59 AM Sources: PharmaLive
Sanofi-Aventis SA subsidiary because of a white substance forming inside some vials. The World Health Organization and the manufacturer of the Shan5 vaccine are investigating the sediment which is "sticking to the glass inside the vials, said Melinda Henry, a World Health Organization spokeswoman. She said there was no indication of a safety risk. Shan5 immunizes against diphtheria, pertussis, tetanus, haemophilus influenza B and hepatitis B. It is produced by Sanofi-Aventis' Indian subsidiary Shantha  

Prev


Be the First to Comment

Add A Comment

  • A confirmation email will be sent to you after submitting.

Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.

More Love.com Network Sites

brand logo

sanofi-aventis-sa.love.com © 2009 All Rights Reserved The Love.com network.